Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 Aug 4;31(9):2136–2143. doi: 10.1161/ATVBAHA.111.228692

Table 1.

Clinical and Biological Variables by Quartile of Pulmonary Surfactant Protein B

Variable Q1 (n=873) Q2 (n=773) Q3 (n=825) Q4 (n=823) p trend
SP-B, ng/mL <1.0 1.0 – 2.6 2.67 – 7.57 7.63 – 829.72
Age, years 39 [33, 47] 43 [36, 51] 45 [37, 54] 47 [40, 54] <0.0001
Men 341 (39%) 331 (43%) 402 (49%) 381 (46%) 0.000
Black 345 (40%) 362 (47%) 464 (56%) 525 (64%) <0.0001
White 294 (34%) 237 (31%) 251 (30%) 192 (23%) <0.0001
Hispanic 209 (24%) 148 (19%) 99 (12%) 98 (12%) <0.0001
Hypertension 212 (25%) 212 (28%) 323 (40%) 355 (44%) <0.0001
Diabetes 81 (9%) 100 (13%) 104 (13%) 101 (12%) 0.072
Metabolic Syndrome 225 (29%) 255 (33%) 293 (36%) 300 (36%) 0.001
Hypercholesterolemia 80 (9%) 95 (12%) 125 (15%) 131 (16%) <0.0001
Low HDL 356 (41%) 316 (41%) 336 (41%) 359 (44%) 0.273
Current Smokers 94 (11%) 117 (15%) 264 (32%) 486 (59%) <0.0001
Former Smokers 137 (16%) 153 (20%) 172 (21%) 94 (12%) 0.056
Never Smokers 641 (73%) 502 (65%) 389 (47%) 240 (29%) <0.0001
Pack-Years (current smokers) 2.9 [0.7, 8.0] 6.9 [1.7, 19.8] 13.1 [5.3, 24.0] 17.5 [8.0, 29.0] <0.0001

SP-B=Pulmonary Surfactant Protein B

Levels of continuous variables are reported as median [IQR] and categorical variables as percentages.